Enovis Appoints Damien McDonald As CEO, Reiterates Q1 Guidance

(RTTNews) - Enovis Corp. (ENOV), a medical technology innovation, on Wednesday announced the appointment of Damien McDonald as Chief Executive Officer, effective on May 12. The company also reaffirmed its first-quarter revenue and adjusted EBITDA.

Matt Trerotola had already informed the Board of the intention to retire as CEO.

Lead Independent Director Sharon Wienbar will assume the role of independent Chair of the Board after Trerotola's retirement.

McDonald is expected to join the company's board as director after the Annual Meeting of Stockholders on May 21. McDonald has more than 35 years of experience in the medical device industry and most recently served as CEO at LivaNova.

The company reiterated its first-quarter revenue to range between $555 and $563 million.

The adjusted EBITDA is anticipated to range between $97 and $100 million.

In the pre-market trading, Enovis is 1.48% lesser at $36.63 on the Nasdaq.